JSJaimin S. Shah

Jaimin S. Shah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jaimin S. Shah has a total of 70 co-authors. Here are the top co-authors by number of shared publications:

  • Alex Dytso

    Qualcomm Flarion Technology, Inc 08807 Bridgewater NJ USA

    1 shared publication
  • Alexander V. Sherman

    Department of Neurology, Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA

    1 shared publication
  • Ali A. Habib

    Department of Neurology University of California Orange California USA

    1 shared publication
  • Ashley B. Pena

    Department of Neurology, Mayo Clinic, Jacksonville, FL, 32224, USA

    1 shared publication
  • Benjamin N. Hoover

    Department of Neurology Columbia University Irving Medical Center New York New York USA

    1 shared publication
  • Bjorn Oskarsson

    Department of Neurology Mayo Clinic Jacksonville Florida USA

    1 shared publication

Latest Publications

  • Expanding the Motor Band Sign in Motor Neuron Disease Using 7T MRI : Visualization of Cortical Layer‐Dependent Iron Deposition in the Primary Motor Cortex

    by Jaimin S. Shah, Björn Oskarsson, Xiangzhi Zhou, Michael G. Heckman, Hanna J. Sledge, Gabriel Virador, Donna Parizadeh, Erik H. Middlebrooks

    Introduction/Aims: There are no established biomarkers of upper motor neuron degeneration to aid in the diagnosis of motor neuron disease (MND). This study examines the diagnostic value of the motor band sign as a marker of upper motor neuron degeneration and its relationship to clinical findings in MND. Methods: Records of consecutive patients who underwent 7T magnetic resonance imaging (MRI) between October 2021 and April 2025 for evaluation of MND or other neurologic indications were retrospectively reviewed. Clinical variables and plasma neurofilament light chain (pNfL) levels were recorded. An upper motor neuron score (Mayo UMNS) was derived from reflex scores. Blinded MRI review assessed the degree of susceptibility‐weighted imaging (SWI) hypointensity in the hand, foot, and bulbar motor cortex regions. Results: An MBS was observed in 100 of 117 (85.5%) MND patients and in 16 (15.5%) patients with non‐MND diagnoses, corresponding to a sensitivity of 85.5% (78.0%–90.7%) and 84.5% (76.2%–90.2%) specificity. The MBS in 78 MND patients (70.9%) preferentially involved the middle and deep cortical layers, giving a trilaminar appearance, while only one non‐MND patient had this finding. Mayo UMNS ( β = 0.89, p < 0.001), pNfL ( β = 0.63, p = 0.033), and age at evaluation ( β = 0.68, p = 0.027) were independently associated with the summed SWI score. Discussion: The 7T MRI MBS is a sensitive and specific marker for MND that complements established clinical evaluation. Using 7T, a trilaminar appearance of the motor cortex, reflecting known histopathological changes, can be visualized and may be specific to MND.


  • Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament Analyses

    by Eric Sorenson, Daragh Heitzman, Ikjae Lee, Grace Jang, Lauren Elman, Ali A. Habib, James Wymer, Ghazala Hayat, Stephen A. Goutman, J. Americo M. Fernandes, et al.

    Background: Primary lateral sclerosis (PLS) is an ultrarare upper motor neuron syndrome with a prognosis unique from classical ALS. The study of PLS is complicated by its rarity and the difficulty distinguishing PLS from ALS. We present data from a 1‐year prospective follow‐up study on PLS and efforts to distinguish it from ALS. Methods: Seventy‐six PLS participants enrolled in this prospective natural history study. EMG studies, blood neurofilament light chain levels (NfLs), and demographic characteristics were obtained at baseline. At 1‐year follow‐up, repeat EMG studies were conducted to determine which participants fulfilled criteria for ALS. Baseline characteristics were then compared to determine features that predict reclassification. Results: Seventy participants completed 1‐year follow‐up. Five of the 70 were reclassified to ALS (7.1%). Those reclassified had higher trends in baseline blood NfL levels (91.4 vs. 34.0 pg/mL, p = 0.13) and shorter symptom duration (39 vs. 69 months in the PLS group, p = 0.15). Reclassification was noted in both probable and definite PLS participants. All cases with a symptomatic duration of less than 2 years retained the PLS phenotype (5 of 5). NfL levels over 90 pg/mL predicted reclassification with 94% specificity and 60% sensitivity. No other features predicted reclassification to ALS. Conclusions: In our population, reclassification of PLS to ALS occurred at a low frequency at 1 year follow‐up (7.1%). Baseline NfL was the strongest predictor in differentiating UMN dominant ALS from PLS at 1‐year follow‐up. Based on our data, we propose EMG and NfL criteria for enrollment in future PLS trials.

  • When is Mimo Massive in Radar?

    by Jaimin Shah, Martina Cardone, Alex Dytso, Cynthia Rush

    This work considers a co-located MIMO radar with M T transmitting and M R receiving antennas in a so-called massive MIMO regime, that is, where the number of virtual spatial antennas N = M T M R is large. Recently, it has been demonstrated that as N grows to infinity, one can fully characterize the false alarm and detection probabilities with very minimal assumptions on the disturbance vector. In this work, these results are partially refined and a lower bound on the probability of detection is provided for any fixed, finite N under certain randomness models for the noise. This result can serve as a rule of thumb for the design of massive MIMO radar systems by indicating the number of antennas required to attain a desired target detection probability.

  • Open Access

    Urine levels of the polyglutamine ataxin-3 protein are elevated in patients with spinocerebellar ataxia type 3

    by Yuka Koike, Karen R. Jansen-West, Rana Hanna Al-Shaikh, Yari Carlomagno, Yuping Song, Judith A. Dunmore, Mark S. LeDoux, Joseph H. Friedman, Ashley B. Pena, Ryan J. Uitti, et al.